A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis

NCT06850480 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Esophagitis (RE)

Interventions

DRUG: JP-1366 simulation tablets
DRUG: Esomeprazole Magnesium (Nexium) simulation tablets

Sponsor

Livzon Pharmaceutical Group Inc.